SpectraCell Laboratories is focused on supporting functional intracellular micronutrient health and is best known for its Intracellular Micronutrient Assay – which measures 31 micronutrients and how they affect cellular function and immunity.
They also offer testing in other areas using blood/serum: nutritional assessment at the cellular level; cardiovascular risk assessment by measuring numbers of lipoprotein particles; and genetic risk assessment for several conditions, including cardiovascular disease, cancers, and neurological illnesses.
SpectraCell Laboratories strives to be a leading laboratory specializing in personalized disease prevention and management.
Founded in 1993, SpectraCell set out to revolutionize medical practice with personalized healthcare. They introduced the micronutrient blood test measuring functional intracellular deficiencies, reflecting metabolic processes and immune status.
In 2006, they expanded to include the Lipoprotein Particle Profile, utilizing patented ultracentrifugation technology for advanced cardiovascular risk assessment. Their commitment to research and development has led to further advancements in cardiovascular health and genetic predisposition testing.
An understanding of biochemical individuality and subclinical deficiencies in chronic disease has driven the solutions provided by Spectracell Laboratories.
Their Purpose is “Taking personalized medicine mainstream.”
Spectracell Laboratory states that “We believe that every patient is biochemically unique, and as medicine progresses in the pursuit of health and wellness, the need for individualized care is becoming increasingly important.
SpectraCell is disrupting the healthcare model by advocating a personalized approach to medicine as the standard of care. We do this by providing access to precision diagnostics designed to empower patients and practitioners to work together to address the underlying causes of disease and promote a healthier future.”
At the core of SpectraCell Laboratories' offerings is the Intracellular Micronutrient Assay, a sophisticated test that measures the levels of 31 essential micronutrients within cells.
SpectraCell’s Micronutrient Test offers a comprehensive analysis of 31 key vitamins, minerals, amino acids, antioxidants, and metabolites at the cellular level. This unique approach provides insight into how well the body utilizes these nutrients, impacting the production of essential substances for growth, development, and health.
Unlike traditional serum tests, this test focuses on functional levels within white blood cells, offering a more accurate and long-term assessment of nutrient status and its impact on health. This test is particularly relevant for assessing metabolic inadequacies and identifying potential causes of chronic conditions.
SpectraCell also offers comprehensive educational support for practitioners. This includes detailed information on their website about tests, the immune response, and patient care planning.
They also offer clinical consultations.
SpectraCell Laboratories is CLIA-Certified.
SpectraCell Laboratories offers a range of specialized diagnostic tests that are crucial for assessing various health aspects, from nutritional deficiencies to cardiovascular risk and genetic markers.
The SpectraCell Micronutrient Test is a cornerstone diagnostic tool that utilizes whole blood to analyze over 30 different vitamins, minerals, and other essential nutrients inside white blood cells.
This comprehensive assessment not only identifies nutritional deficiencies but also evaluates the functional performance of these micronutrients within the body's cells.
This level of detail helps healthcare providers develop personalized treatment plans to address specific deficiencies that may not be evident through typical serum tests alone.
The test's ability to pinpoint functional deficiencies is particularly valuable for guiding nutritional interventions that improve overall health and prevent disease.
The LPP Plus test, conducted via serum samples, focuses on cardiovascular health by measuring 12 different lipoprotein particle markers.
The Lipoprotein Particle Test (LPP) assesses cardiovascular disease risk by measuring lipoprotein particles that carry cholesterol in the blood. Unlike standard cholesterol tests, which only measure total cholesterol levels, the LPP identifies the number and type of lipoprotein particles, providing a more accurate risk assessment.
This test is crucial as it reveals early signs of cardiovascular risk, allowing for proactive treatment to prevent adverse events.
SpectraCell's Telomere Test measures the length of telomeres, which are the protective caps at the ends of chromosomes that shorten with each cell division, eventually leading to cell death and aging.
Telomere length is an indicator of biological aging, and shorter telomeres are associated with a higher risk of age-related diseases and decreased longevity. This whole blood test provides valuable information about a patient's biological age versus their chronological age, which can be instrumental in developing health strategies focused on longevity and aging.
The MTHFR Genotyping test identifies genetic variations in the MTHFR gene using whole blood samples. Individuals with certain variations in this gene may have reduced ability to process folate efficiently, which can increase their risk for conditions such as cardiovascular disease, stroke, and certain types of cancer.
This test is essential for personalized medicine, as it can guide dietary recommendations and folate supplementation, especially in populations at risk for folate-related metabolic issues.
SpectraCell is best known for their Intracellular Micronutrient Assay – measures 31 micronutrients and how they affect cellular function and immunity.
.jpg)
